These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 457860)

  • 1. Tyramine kinetics and metabolism in cirrhosis.
    Faraj BA; Fulenwider JT; Rypins EB; Nordlinger B; Ivey GL; Jansen RD; Ali FM; Camp VM; Kutner M; Schmidt F; Rudman D
    J Clin Invest; 1979 Aug; 64(2):413-20. PubMed ID: 457860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertyraminemia in cirrhotic patients.
    Faraj BA; Bowen PA; Isaacs JW; Rudman D
    N Engl J Med; 1976 Jun; 294(25):1360-4. PubMed ID: 772438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic handling of orally administered glucose in cirrhosis.
    Kruszynska YT; Meyer-Alber A; Darakhshan F; Home PD; McIntyre N
    J Clin Invest; 1993 Mar; 91(3):1057-66. PubMed ID: 8450036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E; Barazzoni R; Tessari P
    Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine metabolism in cirrhosis.
    Nordlinger BM; Fulenwider JT; Ivey GL; Faraj BA; Ali FM; Kutner M; Henderson JM; Rudman D
    J Lab Clin Med; 1979 Dec; 94(6):832-40. PubMed ID: 501206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temazepam clearance unaltered in cirrhosis.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B; Matlis R
    Am J Gastroenterol; 1986 Jan; 81(1):80-4. PubMed ID: 2867675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the fate of tyramine in dogs: the effect of monoamine oxidase inhibition, portafemoral shunt and coronary artery ligation on the kinetics of tyramine.
    Faraj BA; Dayton PG; Camp VM; Wilson JP; Malveaux EF; Schlant RC
    J Pharmacol Exp Ther; 1977 Feb; 200(2):384-93. PubMed ID: 839443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for hypertyraminemia in Reye's syndrome.
    Faraj BA; Newman SL; Caplan DB; Ali FM; Camp VM; Ahmann PA
    Pediatrics; 1979 Jul; 64(1):76-80. PubMed ID: 450566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sufentanil pharmacokinetics in patients with cirrhosis.
    Chauvin M; Ferrier C; Haberer JP; Spielvogel C; Lebrault C; Levron JC; Duvaldestin P
    Anesth Analg; 1989 Jan; 68(1):1-4. PubMed ID: 2521279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolism of riboflavin in female patients with liver cirrhosis.
    Zempleni J; Galloway JR; McCormick DB
    Int J Vitam Nutr Res; 1996; 66(3):237-43. PubMed ID: 8899458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion.
    Tessari P; Kiwanuka E; Vettore M; Barazzoni R; Zanetti M; Cecchet D; Orlando R
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G598-604. PubMed ID: 18653725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Consequences of hyperglycemia on glucose and nitrogen metabolism in liver cirrhosis. A study using a hyperglycemic clamp].
    Vetter D; Fratte S; Winiszewski P; Reville M; Hirsch E; Roze F; Blickle JF; Pinget M; Doffoel M; Bockel R
    Gastroenterol Clin Biol; 1990; 14(5):483-91. PubMed ID: 2194890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon and insulin metabolism in cirrhotic patients.
    Yoshida T; Ninomiya K; Matsumoto T; Baatar D; Bandoh T; Kitano S
    Hepatogastroenterology; 1998; 45(20):468-71. PubMed ID: 9638429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin response and clearance in acute and chronic liver disease.
    Sette H; Hughes RD; Langley PG; Gimson AE; Williams R
    Thromb Haemost; 1985 Oct; 54(3):591-4. PubMed ID: 4089794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine clearance is impaired in alcoholic cirrhosis.
    Leighton JA; Bay MK; Maldonado AL; Schenker S; Speeg KV
    Hepatology; 1991 Dec; 14(6):1013-5. PubMed ID: 1959847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine disposition in severe hepatic cirrhosis.
    Gonzalez-Martin G; Paulos C; Veloso B; Chesta J; Novoa X; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):139-42. PubMed ID: 3557740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of an increased nitric oxide production in primary biliary cirrhosis.
    Battista S; Bar F; Mengozzi G; Pollet C; Torchio M; Cavalli G; Rosina F; David E; Cutrin JC; Cavalieri B; Poli G; Molino G
    Am J Gastroenterol; 2001 Mar; 96(3):869-75. PubMed ID: 11280567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol metabolism in liver cirrhosis and chronic alcoholism.
    Ginestal da Cruz A; Correia JP; Menezes L
    Acta Hepatogastroenterol (Stuttg); 1975 Dec; 22(6):369-74. PubMed ID: 1211063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of epinephrine on glucose metabolism in patients with alcoholic cirrhosis.
    Schricker T; Albuszies G; Weidenbach H; Beckh K; Ensinger H; Anhäupl T; Radermacher P; Vogt J; Adler G; Georgieff M
    Hepatology; 1996 Aug; 24(2):330-6. PubMed ID: 8690401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.